Magnesium and heart failure

Molecular Aspects of Medicine

Volumn 24, Issue 1-3, 2003, Pages 79-105

  Delva, Pietro ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMILORIDE; BENDROFLUMETHIAZIDE; CALCIUM; CATECHOLAMINE; CHLOROTHIAZIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DEOXYCORTICOSTERONE ACETATE; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; LOOP DIURETIC AGENT; MAGNESIUM; MILRINONE; PHOSPHODIESTERASE INHIBITOR; POTASSIUM; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ADRENERGIC SYSTEM; AGE; ALDOSTERONE BLOOD LEVEL; CELL MEMBRANE TRANSPORT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE MARKER; DRUG EFFECT; ENERGY; FIBROBLAST; HEART FAILURE; HEART FUNCTION; HEART MUSCLE; HEART VENTRICLE FUNCTION; HOMEOSTASIS; HORMONE ACTION; HUMAN; HYPERTENSION; HYPOMAGNESEMIA; MAGNESIUM DEFICIENCY; NONHUMAN; PATHOGENESIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SUDDEN DEATH; SURVIVAL;

ALDOSTERONE; ANIMALS; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; ENERGY METABOLISM; HUMANS; MAGNESIUM; MYOCARDIAL CONTRACTION; NEUROTRANSMITTER AGENTS;

DIGITALIS;

EID: 0037421541     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(02)00093-6     Document Type: Review

References (130)

1. Abraham A.S., Meshulam Z., Rosenmann D., Eylath U. Influence of chronic diuretic therapy on serum, lymphocyte and erythrocyte potassium, magnesium and calcium concentrations. Cardiol. 75:1988;17-23.
2. Abraham A., Brooks B.A., Grafstein Y., Barchilon E., Nubani N., Eylath U., Shemesh O. Effects of Hydrochlorothiazied, diltiazem and enalapril on mononuclear cell sodium and magnesium levels in systemic hypertension. Am. J. Cardiol. 68:1991;1357-1361.
3. Ahn H.Y., Karaki H., Urakawa N. Deficiency of external Ca and Mg increases membrane permeability in the vascular smooth muscle of rabbit aorta. Arch. Intern. Pharmac. Ther. 272:1984;236-244.
4. Altura B.M. Influence of magnesium on drug-induced contractions and ion content in rabbit aorta. Am. J. Physiol. 220:1971;938-944.
5. + -ATPase and the extracellular action of magnesium ions in arterial smooth muscle Artery. 3:1977;72-83.
6. Altura B.M., Barbour R.L., Dowd T.L., Wu F., Altura B.T., Gupta R.K. Low extracellular magnesium induces intracellular free magnesium deficits, ischemia, depletion of high-energy phosphates and cardiac failure in intact working rat hearts: a 31P-NMR study. Biochim. Biophys. Acta Molec. Dis. 1182:1993;329-332.
7. Atarashi K., Matsuoka H., Takagi M., Sugimoto T. Magnesium ion: a possible regulator of aldosterone production. Life Sci. 44:1989;1483-1489.
8. Bloom S. Reversible and irreversible injury: calcium as a major determinant. Balazs T. Cardiac Toxicology. 1981;179-199 CRC Press, Boca Raton, FL.
9. Bloom S. Magnesium deficiency cardiomyopathy. Am. J. Cardiovasc. Path. 2:1988;7-17.
10. Brandt G., Dorfelt H.J. Postmortem magnesium concentrations in heart and skeletal muscle, liver and brain in different diseases of man. Magnesium Bull. 1:1979;140-142.
11. Braunwald E. Normal and abnormal myocardial function. Brauwald E., Hauser S.L., Fauci A.S., Longo D.L., Kasper D.L., Jameson J.L. Harrison's Principles of Internal Medicine. fifteen ed. 2001;1309-1318 McGraw-Hill Medical Publishing Division, New York.
12. Brilla C.G., Weber K.T. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc. Res. 26:1992;671-677.
13. Campbell S.E., Diaz-Arias A.A., Weber K.T. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press. 1:1992;149.
14. 2+ transport and ATPase activity in sarcoplasmic reticulum vesicles Arch. Biochem. Biophys. 208:1981;586-592.
15. Cleland J.G. The renin-angiotensin system in heart failure. Herz. 16:1991;68-81.
16. Cleland J.G.F., Dargie H.J., Hodsman G.P.et al. Captopril in heart failure: a double blind controlled trial. Br. Heart J. 52:1984;530-535.
17. Cleland J.G.F., Dargie H.J., Ball S.G., Gillen G., Hodsman G.P., Morton J.J., East B.W., Robertson I., Ford I., Robertson J.I.S. Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones and metabolic state. Br. Heart J. 54:1985;305-312.
18. Delva P., Lechi A., Pastori C., Degan M., Sheiban I., Montesi G., Pea M., Meneguzzi A., Menegazzi M. Collagen I and III mRNA gene expression and cell growth potential of skin fibroblasts in patients with essential hypertension. J. Hypertens. 20:2002;1393-1399.
19. Delva P., Pastori C., Degan M., Montresor, Montesi G., Lechi A. Intralymphocyte free magnesium and cardiac anatomy and function in a group of patients with essential hypertension. Smetana R. Advances in Magnesium Research. 1995;93-95 John Libbey & Company Ltd. London, England.
20. Delva P., Pastori C., Degan M., Montesi G., Brazzarola P., Lechi A. Intralymphocyte free magnesium in patients with primary aldosteronism: aldosterone and lymphocyte magnesium homeostasis. Hypertension. 35:2000;113-117.
21. Diéz J., Laviades C. Insulin-like growth factor I and collagen type III synthesis in patients with essential hypertension and left ventricular hypertrophy. J. Hum. Hypertens. 8(Suppl. 1):1994;S21-S25.
22. Dorup I., Skajaa K., Clausen T., Kjeldsen K. Reduced concentrations of potassium, magnesium, and sodium-potassium pumps in human skeletal muscle during treatment with diuretics. Br. Med. J. 296:1988;455-458.
23. Duprez D.A., De Buyzere M.L., Reitzschel E.R.et al. Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients. Eur. Heart J. 19:1998;1371-1376.
24. Dyckner T., Wester P.O. Ventricular extrasystoles and intracellular electrolytes before and after potassium and magnesium infusions in patients on diuretic treatment. Am. Heart J. 97:1979;12-18.
25. Dyckner T., Wester P.O. Intracellular magnesium loss after diuretic administration. Drugs. 28:1984a;161-166.
26. Dyckner T., Wester P.O. Magnesium deficiency in congestive heart failure. Acta Pharmacol. Toxicol. Copenh. 1:1984b;119-123.
27. Dyckner T., Wester P.O. Skeletal muscle magnesium and potassium determinations: correlations with lymphocyte contents of magnesium and potassium. J. Am. College Nutr. 4:1985;619-625.
28. Dyckner T., Wester P.O., Widman L. Amiloride prevents thiazide-induced intracellular potassium and magnesium losses. Acta Med. Scand. 224:1988;25-30.
29. Eichhorn E.J. Our new understanding of heart failure: the role of beta-blockers in treatment. Cleve. Clin. J. Med. 65:1998;428-435.
30. Eichhorn E.J., Tandon P.K., DiBianco R., Timmis G.C., Fenster P.E., Shannon J., Packer M. Clinical and prognostic significance of serum magnesium concentration in patients with severe chronic congestive heart failure: the PROMISE study. J. Am. Coll. Cardiol. 21:1993;634-640.
31. Evans P.H., Sweeney K., Keenan H., Luthra M., Gray D.P. Benefit of. β -blockers for heart failure Lancet. 354:1999;682.
32. 2+ during metabolic stimulation of rat cardiac myocytes and perfused hearts Archiv. Biochem. Biophys. 374:2000;395-401.
33. Fazekas M.A., Scherlag B.J., Vos M., Wellens H.J., Lazzara R. Magnesium and the heart: antiarrhythmic therapy with magnesium. Clin. Cardiol. 16:1993;768-774.
34. Fisher P.W.F., Giroux A. Effects of dietary magnesium on sodium-potassium pump action in the heart of rats. J. Nutr. 117:1987;2091-2095.
35. Flatman P.W. Regulation of potassium transport by magnesium. Reuss L., Russell J.M., Szabo G. Regulation of Potassium Transport Across Biological Membranes. vol. 9:1990;191-212 University of Texas Press, Austin, TX.
36. Fuster V., Gersh B.J., Giuliani E.R., Tajik A.J., Brandemburg R.D., Frye R.L. The natural history of idiopathic dilated cardiomyopathy. Am. J. Cardiol. 47:1981;525-531.
37. Garfinkel D., Garfinkel L. Magnesium and regulation of carbohydrate metabolism at the molecular level. Magnesium. 7:1988;249-261.
38. 2+ pump of plasma membranes:1986;127-136 CRC Press, Boca Raton, FL.
39. Gottlieb S.S., Baruch L., Kukin M.L., Bernstein J.L., Fisher M.L., Packer M. Prognostic importance of the serum magnesium concentration in patients with congestive heart failure. J. Am. Coll. Cardiol. 16:1990;827-831.
40. Greeberg A. Diuretic complications. Am. J. Med. Sci. 319:2000;10-24.
41. Greenberg D.M., Anderson C.E., Tufts E.V. Pathological changes in the tissues of rats reared on diets low in magnesium. J. Biol. Chem. 114:1936;xlii.
42. Grubbs R.D., Maguire M.E. Magnesium as a regulatory cation: criteria and evaluation. Magnesium. 6:1987;113-127.
43. Guarda E., Myers P.R., Brilla C.G., Tyagi S.C., Weber K.T. Endothelial cell induced modulation of cardiac fibroblast collagen metabolism. Cardiovasc. Res. 23:1993;1004-1008.
44. Guicheney P., Wauquier I., Paquet J.L., Meyer P. Enhanced response to growth factors and to angiotensin II of spontaneously hypertensive rat skin fibroblasts in culture. J. Hypertens. 9:1991;23-27.
45. 2+ -loaded erythrocytes Biochem. Biophys. Acta. 1023:1990;455-461.
46. Haenni A., Lind L., Lithell H. The blood pressure response to antihypertensive treatment with lisinopril or bendrofluazide is related to the calcium and magnesium contents in skeletal muscle. J. Hypertens. 9:1996;273-276.
47. Haissaguerre M., Fleury B., Gueguen A., Bonet J., Loerente P., Nakache J.P. Mortalitedé des myocardiopathies dilatées en fonction de la poursuite de l'alcoollisation. Analyse multivariaée sur 236 malades. Press. Méd. 18:1989;711-714.
48. Hartzell H.C., White R.E. Effects of magnesium on inactivation of the voltage-gated calcium current in cardiac myocytes. J. Gen. Physiol. 94:1989;745-767.
49. Heggtveit H.A. The cardiomyopathy of magnesium-deficiency. Bajusz E. Electrolyte and Cardiovascular Diseases. 1965;204-220 S. Karger, Basel/New York.
50. Hene R.J., Koomans H.A., Dorhout-Mees E.J., van der Stolpe A., Verhoef G.E., Boer P. Correction of hypokalemia in Barterr's syndrome by enalapril. Am. J. Kidney Dis. 9:1987;200-205.
51. Hensen J., Abraham W.T., Durr J.A., Schrier R.W. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention. Am. J. Nephrol. 11:1991;441-446.
52. Horie M., Irisawa H., Noma A. Voltage-dependent magnesium block of adenosine-triphosphate-sensitive potassium channel in guinea-pig ventricular cells. J. Physiol. (London). 387:1987;251.
53. Horton P., Biglieri E.G. Effect of aldosterone on the metabolism of magnesium. J. Clin. Endocr. Metab. 22:1962;1187-1192.
54. Howarth F.C., Levi A.J. Internal free magnesium modulates the voltage dependence of contraction and Ca transient in rabbit ventricular myocytes. Pflugers Arch. 435:1998;687-698.
55. Ichihara A., Suzuki H., Saruta T. Effects of magnesium on the renin-angiotensin-aldosterone system in human subjects. J. Lab. Clin. Med. 122:1993;432-440.
56. Iseri L.T., Alexander L.C., McCaughey R.S., Boyle A.J., Myers G.B. Water and electrolyte content of cardiac and skeletal muscle in heart failure and myocardial infarction. Am. Heart J. 43:1952;215-227.
57. Iseri L.T., Boyle A.J., Chandler D.E., Myers G.B. Electrolyte studies in heart failure. Cellular factors in the pathogenesis of the edema of congestive heart failure. Circulation. 11:1955;615-627.
58. + current in guinea pig cardiac myocytes J. Physiol. 419:1989;297.
59. Kannel W.B. Epidemiological aspects of heart failure. Cardiol. Clin. 7:1989;1-9.
60. Kisch E.S., Dluhy R.G., Williams G.H. Regulation of renin release by calcium and ammonium ions in normal man. J. Clin. Endocrinol. Metab. 43:1976;1343-1350.
61. Kleiger R.E., Katsutaka S. Effects of chronic depletion of potassium and magnesium upon the action of acetylstrophantidin. Am. J. Cardiol. 17:1966;520.
62. Klug D., Robert V., Swynghedauw B. Role of mechanical and hormonal factors in cardiac remodelling and the biologic limits of myocardial adaptation. Am. J. Cardiol. 71:1993;46A-54A.
63. Kumar B.P., Shivakumar K. Depressed antioxidant defense in rat heart in experimental magnesium deficiency. Implications for the pathogenesis of myocardial lesions. Biol. Trace Elem. Res. 60:1997;139-144.
64. Kumar B.P., Shivakumar K., Kartha C.C. Magnesium deficiency-related changes in lipid peroxidation and collagen metabolism in vivo in rat heart. Int. J. Biochem. Cell. Biol. 29:1997;129-134.
65. Kurantsin-Mills J., Cassidy M.M., Stafford R.E., Weglicki W.B. Marked alterations in circulating inflammatory cells during cardiomyopathy development in a magnesium-deficient rat model. Br. J. Nutr. 78:1997;845-855.
66. Lommer D., Dusterdiek G., Jahnecke J., Wolff H.P. Untersuchungen liber die sekretinsrute, die matabolische clearancerate und die plasmakonzentration von aldosteron beim menschen. Verh. Dtsch. Ges. Inn. Med. 71:1965;386.
67. Lowenhaupt E., Schulman M.P., Greenberg D.M. Basic histologic lesions of magnesium deficiency in the rat. Arch. Path. 49:1950;427.
68. Luetscher J.A., Camargo C.A., Hancock E.W., Dowdy A.J., Nokes G.W. Observations of aldosterone metabolism in congestive heart failure. Trans. Assoc. Am. Physicians. 77:1964;224.
69. Mader I.J., Iseri L.T. Spontaneous hypopotassemia, hypomagnesemia, alkalosis and tetany due to hypersecretion of corticosterone-like mineralocorticoid. Am. J. Med. (December):1955;976-988.
70. Malini P.L., Strocchi E., Valtancoli G., Ambrosioni E. Angiotensin converting enzyme inhibitors, thiazide diuretics and magnesium balance. A preliminary study. Magnesium Res. 3:1990;193-196.
71. Marshall S., Bacote V., Traxinger R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. J. Biol. Chem. 266:1991;4706-4712.
72. Massry S.G. Role of hormonal and non-hormonal factors in the control of renal handling of magnesium. 3rd International Symposium on Magnesium, Baden-Baden 1981. Magnesium Bull. 3(1a):1981;277.
73. Massry S.G., Coburn J.W. The hormonal and non-hormonal control of renal excretion of calcium and magnesium. Nephron. 10:1973;66-112.
74. Massie B.M., Conway M. Survival of patients with congestive heart failure: past, present and future prospects. Circulation. 75(Suppl. IV):1987;IV-II-9.
75. Massry S.G., Coburn J.W., Chapman L.W., Kleeman C.R. The acute effect of adrenal steroids on the interrelationship between the renal excretion of sodium, calcium and magnesium. J. Lab. Clin. Med. 70:1967;563-570.
76. Matsuda H. Open-state substructure of inwardly rectifying potassium channels revealed by magnesium block in guinea-pig heart cells. J. Physiol. 397:1988;237-258.
77. Mishra R.K. Studies on experimental magnesium deficiency in the albino rat. Rev. Canad. Biol. 19:1960;122.
78. Morgan D.B., Davidson C. Hypolalaemia and diuretics: an analysis of publications. Br. Med. J. 280:1980;905-908.
79. Ng L.L., Garrido C., Davies J.E., Brochwicz-Lewinski M.J., Tan L.B. Intracellular free magnesium in lymphocytes from patients with congestive heart failure treated with loop diuretics with and without amiloride. Br. J. Clin. Pharmacol. 33:1992;329-332.
80. Nieminen A.L., Gores G.J., Dawson T.L., Herman B., Lemasters J.J. Toxic injury from mercuric chloride in rat hepatocytes. J. Biol. Chem. 265:1990;2399-2408.
81. Osler W. The Principles and Practice of Medicine. 1895;Young J Pentland, Edinburgh.
82. Packer M. Sudden unexpected death in patients with congestive heart failure: a second frontier. Circulation. 72:1985;681-685.
83. Packer M., Gottlieb S.S., Kessler P.D. Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: basis of a new physiologic approach to control of arrhythmia. Am. J. Med. 80(Suppl 4A):1986;23-29.
84. Philips N., Bashey R.I., Jimenez S.A. Collagen and fibronectin expression in cardiac fibroblasts fron hypertensive rats. Cardiovasc. Res. 28:1994;1342-1347.
85. Pirani C.L., Stepto R.C., Sutherland K. Deoxycorticosterone acetate and wound healing. J. Exp. Med. 93:1951;217.
86. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 341:1999;709-717.
87. Potts J.L., Dalakos T.G., Streeten D.H.P., Jones D. Cardiomyopathy in an adult with Barterr's syndrome: hemodynamic, angiographic, and matabolic studies. Am. J. Cardiol. 40:1977;995.
88. Quamme G.A. Renal magnesium handling: new insights in understanding old problems. Kidney Int. 52:1997;1180-1195.
89. Ralston M.A., Murnane M.R., Kelley R.E., Altschuld R.A., Unverferth D.V., Leier C.V. Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation. 80:1989;573-580.
90. Resnick L.M., Laragh J.H. Calcium metabolism and parathyroid function in primary aldosteronism. Am. J. Med. 78:1985;385-390.
91. Rigo J., Simon G., Hegyvari C., Sos J. Effect of magnesium on dietary infarctoid changes in the heart. Acta Med. Acad. Sci. Hung. 19:1963;231-236.
92. Robert V., Thiem N.V., Cheav S.L., Mouas C., Swynghedauw B., Delcayre C. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension. 24:1994;30-36.
93. 2+ efflux from liver cells FEBS Lett. 269:1990;37-40.
94. Romani A., Marfella C., Scarpa A. Regulation of magnesium uptake and release in the heart and in isolated ventricular myocytes. Circ. Res. 72:1993;1139-1148.
95. 2+ accumulation by insulin in rat hearts and cardiac ventricular myocytes Circ. Res. 86:2000;326-333.
96. Rona G. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17:1985;291-306.
97. Ross E.J. Aldosterone and Aldosteronism. 1975;114-143 Lloyd-Luke Ltd. London.
98. Rossi M.A., Peres L.C., Preto R. Effects of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy. Am. Heart J. 124:1992;700-709.
99. Ryan M.P., Ryan M.F., Counihan T.B. The effect of diuretics on lymphocyte magnesium and potassium. Acta Med. Scand. 647:1981;153-161.
100. + in Ehrlich ascites tumor cells Acta Biol. Med. Ger. 39:1980;177-184.
101. Seelig M. Cardiovascular consequences of magnesium deficiency and loss: pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am. J. Cardiol. 63:1989;4G-21G.
102. Shine K., Douglas A.M. Magnesium effect on ionic exchange and mechanical function in the rat ventricle. Am. J. Physiol. 227:1974;317.
103. Smith W.M. Epidemiology of congestion heart failure. Am. J. Cardiol. 55:1985;3A-8.
104. Specter M.J., Schweizer E., Goldman R.H. Studies on magnesium's mechanism of action in digitalis-induced arrhythmias. Circulation. 52:1975;1001-1005.
105. Steiness E. Suppression of renal excretion of digoxin in hypokalemic patients. Clin. Pharmacol. Ther. 23:1978;511-514.
106. Stevenson R.N., Keywood C., Amadi A.A., Davies J.R., Patterson D.L.H. Angiotensin converting enzyme inhibitors and magnesium conservation in patients with congestive cardiac failure. Br. Heart J. 66:1991;19-21.
107. Swales J.D. Magnesium deficiency and diuretics. Br. Med. J. 285:1982;1377-1378.
108. Tan L.B., Mills J., Wright D.J. Management of heart failure. J. R Coll. Physicians London. 33:1999;25-30.
109. Toda N., West T.C. Interaction between Na, Ca and Mg and vagal stimulation in the SA node of the rabbit. Am. J. Physiol. 212:1967;424-430.
110. 2+ exchange in cardiac sarcolemmal vesicles Biochim. Biophys. Acta. 731:1983;63-68.
111. Vandenberg C.A. Inward rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc. Natl. Acad. Sci. USA. 84:1987a;256.
112. Vandenerg C.A. Internal rectification of a potassium channel in cardiac ventricular cells depends on internal magnesium ions. Proc. Natl. Acad. Sci. USA. 84:1987b;2560-2564.
113. Vandenburg M.J., Robinson P., Arr S., Cooper W., Currie W.J.C. Serum magnesium is unaffected by angiotensin converting enzyme inhibition. Clin. Sci. 68(Suppl. 1):1985;77-78.
114. Vitale J.J., Hellerstein E.E., Nakamura M., Lown B. Effects of magnesium-deficient diet upon puppies. Circulat. Res. 9:1961;387.
115. Vorman V.J., Gunther T., Leder O. Effect of isoproterenol and phenylephrine on the hearts of Mg deficient rats. Magnesium Bull. 2:1981;130-134.
116. 2+ efflux from isolated perfused rat hearts Magnesium. 6:1987;220-224.
117. Wacker W.E.C. Adenosine triphosphatases. Magnesium and Man. 1980;40-45 Harvard University Press, Cambridge, MA.
118. Whang R., Aikawa J.K. Magnesium deficiency and refractoriness to potassium repletion. J. Chron. Dis. 30:1977;65-68.
119. Whang R., Welt L. Observations in experimental magnesium depletion. J. Clin. Invest. 42:1983;305-313.
120. Whang R., Morosi H.et al. The influence of sustained magnesium deficiency on muscle potassium repletion. J. Lab. Clin. Med. 70:1967;895-902.
121. Whang R., Flink E.B.et al. Magnesium depletion as a cause of refractory potassium repletion. Arch. Intern. Med. 145:1985;1686-1689.
122. White R.E., Hartzell H.C. Effects of intracellular free magnesium on calcium current in isolated cardiac myocytes. Science. 239:1988;778-780.
123. White R.E., Hartzell H.C. Magnesium ions in cardiac function. Regulator of ion channels and second messengers. Biochem. Pharmacol. 38:1989;859-867.
124. Wolff H.P., Lommer D., Torbica M. Studies on plasma aldosterone in some heart, liver and kidney diseases. Sch. Med. Wochenschr. 95:1965;387.
125. Wu F., Barbour R.L., Altura B.T., Altura B.M. Influence of elevated versus low extracellular magnesium on hemodynamics and bioenergetics in perfused rat hearts. FASEB J. 2:1988;A702.
126. Wu F., Zou L.Y., Altura B.T., Barbour R.L., Altura B.M. Low extracellular magnesium results in cardiac failure in isolated perfused rat hearts. Magnesium. 10:1992;364-373.
127. Yan J., Lawson J.E., Reed L.J. Role of the regulatory subunit of bovine pyruvate dehydrogenase phosphatase. Proc. Natl. Acad. Sci. USA. 14:1996;4953.
128. Yoshikawa T., Handa S., Anzai T., Nishimura H., Baba A., Akaishi M., Mitamura H., Ogawa S. Early reduction of neurohormonal factors plays a key role in mediating the efficacy of. β -blocker therapy for congestive heart failure Am. Heart J. 131:1996;329-336.
129. Young M.et al. Determinants of cardiac fibrosis in experimental mineral corticoid states. Am. J. Physiol. 269:1995;E657-E662.
130. Zumkley V.H., Bertram H.P.et al. Magnesium and zinc concentrations in plasma and erythrocytes under angiotensin converting enzyme inhibition. Magnesium Bull. 2:1983;74-77.